Diagnosis of autoimmune hepatitis
DOI:
https://doi.org/10.52784/27112330.113Keywords:
autoimmune hepatitis, autoimmune diseases, liver cirrhosis, liver transplantation.Abstract
Autoimmune hepatitis is an inflammatory disease of the liver of unknown etiology. It is characterized by the presence of autoantibodies and elevated levels of serum globulins. It affects both genders, all age groups and has been described in all races. It has a wide variety of clinical manifestations, so it remains a diagnostic challenge for physicians. The most common form of manifestation is acute hepatitis, however a non-negligible percentage of patients is asymptomatic, and up to 40% of cases have cirrhosis at the time of diagnosis. The diagnosis is based on: 1) measurement of autoantibodies, such as antinuclear antibodies (ANA), anti-smooth muscle antibodies (ASMA), and liver/kidney microsomal type 1 antibodies (anti-LKM-1); 2) detection of elevated serum levels of globulins (especially IgG); 3) exclusion of other causes of chronic hepatitis; and, 4) histological findings, which also confirm the diagnosis and help determine its severity. Diagnosticscales and scores have been developed to allow a better approach to this pathology without replacing the clinical judgment, so they must be interpreted under an adequate clinical context. A proper diagnosis can allow a timely initiation of treatment in order to decrease the progression and the development of complications.
Downloads
References
Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis-Update 2015. J Hepatol 2015;62:S100-111. https://doi.org/10.1016/j.jhep.2015.03.005.
Czaja AJ. Diagnosis and management of autoimmune hepatitis: Current status and future directions. Gut Liver 2016;10:177-203. https://doi.org/10.5009/gnl15352.
Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 2008;48:140-147. https://doi.org/10.1016/j.jhep.2007.08.013.
Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology 2007;46:1828-1835. https://doi.org/10.1002/hep.21884.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol 2015;63:971-1004. https://doi.org/10.1016/j.jhep.2015.06.030.
Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-547. https://doi.org/10.1002/hep.510250308.
Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 2002;8:505-513. https://doi.org/10.1053/jlts.2002.33485.
Kerkar N, Hadzic N, Davies ET, Portmann B, Donaldson PT, Rela M, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998;351:409-413. https://doi.org/10.1016/S0140-6736(97)06478-7.
González-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, et al. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 2001;7:302-310. https://doi.org/10.1053/jlts.2001.21449.
Stirnimann G, Ebadi M, Czaja AJ, Montano-Loza AJ. Recurrent and de novo autoimmune hepatitis. Liver Transpl 2019;25:152-166. https://doi.org/10.1002/lt.25375.
Martínez-Casas OY, Díaz-Ramírez GS, Marín-Zuluaga JI, Muñoz-Maya O, Santos O, Donado-Gómez JH, et al. Differential characteristics in drug-induced autoimmune hepatitis. JGH Open 2018;2:97-104. https://doi.org/10.1002/jgh3.12054.
Bjornsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 2010;51:2040-2048. https://doi.org/10.1002/hep.23588.
Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005. https://doi.org/10.1002/hep.1840180435.
Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938. https://doi.org/10.1016/S0168-8278(99)80297-9.
Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-176. https://doi.org/10.1002/hep.22322.
Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005;42:53-62. https://doi.org/10.1002/hep.20732.
Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol 2002;35:75-81. https://doi.org/10.1097/00004836-200207000-00016.
Díaz-Ramírez GS, Marín-Zuluaga JI, Donado-Gómez JH, Muñoz-Maya O, Santos-Sánchez O, Restrepo-Gutiérrez JC. Characterization of patients with autoimmune hepatitis at an university hospital in Medellín-Colombia: cohort study. Gastroenterol Hepatol 2018;41:87-96. https://doi.org/10.1016/j.gastrohep.2017.09.003.
Czaja AJ. Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci 2013;58:897-914. https://doi.org/10.1007/s10620-012-2445-4.
Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 1994;21:866-871. https://doi.org/10.1016/S0168-8278(94)80251-3.
Aljumah AA, Al-Ashgar H, Fallatah H, Albenmousa A. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes. Ann Hepatol 2019;18:439-444. https://doi.org/10.1016/j.aohep.2018.09.001.
Yasui S, Fujiwara K, Yonemitsu Y, Oda S, Nakano M, Yokosuka O. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol 2011;46:378-390. https://doi.org/10.1007/s00535-010-0316-3.
Fujiwara K, Fukuda Y, Yokosuka O. Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis. J Gastroenterol 2008;43:951-958. https://doi.org/10.1007/s00535-008-2254-x.
Bernal W, Ma Y, Smith HM, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007;47:664-670. https://doi.org/10.1016/j.jhep.2007.05.011.
Stravitz RT, Lefkowitch JH, Fontana RJ, Gershwin ME, Leung PS, Sterling RK, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011;53:517-526. https://doi.org/10.1002/hep.24080.
Udell JA, Wang CS, Tinmouth J, FitzGerald JM, Ayas NT, Simel DL, et al. Does this patient with liver disease have cirrhosis? JAMA 2012;307:832-842. https://doi.org/10.1001/jama.2012.186.
Wong GW, Yeong T, Lawrence D, Yeoman AD, Verma S, Heneghan MA. Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes. Liver Int 2017;37:449-457. https://doi.org/10.1111/liv.13236.
Gronbaek L, Vilstrup H, Pedersen L, Jepsen P. Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study. Liver Int 2019;39:205-214. https://doi.org/10.1111/liv.13963.
Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 2006;45:575-583. https://doi.org/10.1016/j.jhep.2006.04.007.
Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Worns M, et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 2010;44:208-213. https://doi.org/10.1097/MCG.0b013e3181c74e0d.
Zychowska M, Wozniak Z, Maj J. Vulvovaginal-gingival-pilar lichen planus in a patient with autoimmune hepatitis. Int J Dermatol 2018;57:1500-1501. https://doi.org/10.1111/ijd.14184.
Halac U, Al Dhaybi R, Powell J, Bouron-Dal Soglio D, Álvarez F. Unusual association between autoimmune hepatitis and severe pyoderma gangrenosum. J Pediatr Gastroenterol Nutr 2010;50:219-221. https://doi.org/10.1097/MPG.0b013e31819a62f5.
Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E, et al. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011;54:374-385. https://doi.org/10.1016/j.jhep.2010.09.002.
Martínez-Casas OY, Díaz-Ramírez GS, Marín-Zuluaga JI, Santos O, Muñóz-Maya O, Donado-Gómez JH, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital. Gastroenterol Hepatol 2018;41:544-552. https://doi.org/10.1016/j.gastre.2018.11.006.
Czaja AJ. Autoantibody-negative autoimmune hepatitis. Dig Dis Sci 2012;57:610-624. https://doi.org/10.1007/s10620-011-2017-z.
Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987;7:1333-1339. https://doi.org/10.1002/hep.1840070626.
Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992;103:1290-1295. https://doi.org/10.1016/0016-5085(92)91518-9.
Mehendiratta V, Mitroo P, Bombonati A, Navarro VJ, Rossi S, Rubin R, et al. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol 2009;7:98-103. https://doi.org/10.1016/j.cgh.2008.08.043.
Vergani D, Alvarez F, Bianchi FB, Cancado EL, Mackay IR, Manns MP, et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004;41:677-683. https://doi.org/10.1016/j.jhep.2004.08.002.
Baeres M, Herkel J, Czaja AJ, Wies I, Kanzler S, Cancado EL, et al. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 2002;51:259-264. https://doi.org/10.1136/gut.51.2.259.
Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, et al. Autoimmune hepatitis. Nat Rev Dis Primers 2018;4:18017. https://doi.org/10.1038/nrdp.2018.17.
Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 1999;30:394-401. https://doi.org/10.1016/S0168-8278(99)80096-8.
Czaja AJ, Carpenter HA. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 2001;34:659-665. https://doi.org/10.1053/jhep.2001.27562.
Hofer H, Oesterreicher C, Wrba F, Ferenci P, Penner E. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol 2006;59:246-249. https://doi.org/10.1136/jcp.2005.029348.
Shen Y, Lu C, Men R, Liu J, Ye T, Yang L. Clinical and pathological characteristics of autoimmune hepatitis with acute presentation. Can J Gastroenterol Hepatol 2018;2018:3513206. https://doi.org/10.1155/2018/3513206.
Wu S, Yang Z, Zhou J, Zeng N, He Z, Zhan S, et al. Systematic review: diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitis. Hepatol Int 2019;13:91-101. https://doi.org/10.1007/s12072-018-9907-5.
Gassert DJ, Garcia H, Tanaka K, Reinus JF. Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis. Dig Dis Sci 2007;52:2433-2437. https://doi.org/10.1007/s10620-006-9665-4.
Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 2008;48:1540-1548. https://doi.org/10.1002/hep.22513.
Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC, et al. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology 2009;50:538-545. https://doi.org/10.1002/hep.23042.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
La política de reconocimiento de autoría de Hepatología se basa en los criterios indicados por el ICMJE para conferir crédito de un trabajo a una persona, a la vez que se le atribuye responsabilidad por la publicación del mismo.
